by Jessica Casebolt | Jul 31, 2023 | Life Sciences, Tea Leaves
Johnson & Johnson on Tuesday became the latest drugmaker to go to court to halt Medicare drug price negotiations established by the Inflation Reduction Act. The lawsuit increases the odds that negotiated prices won’t take effect on schedule, beginning in...
by Jessica Casebolt | Jul 31, 2023 | D.C. News, Tea Leaves
The White House plans to impose a 10-year funding ban on the Wuhan Institute of Virology, the lab at the center of the COVID-19 origins debate, according to a government memo and an official familiar with the issue. The memo, written by an official at the Department...
by Jessica Casebolt | Jul 31, 2023 | Tea Leaves, Transition to Value
Efforts to move dialysis care into the home are gaining traction three years after then-President Donald Trump set a goal of having 80 percent of newly diagnosed kidney failure patients receive transplants or home dialysis by 2025. Last year, 26.6 percent of Medicare...
by Jessica Casebolt | Jul 31, 2023 | Providers, Tea Leaves
The Lown Institute released its ranking of the most socially responsible hospitals, with just 54 out of 3,600 receiving “A” grades for their work across the three main categories of equity, value, and outcomes. The Lown Institute is a health care think tank that...
by Jessica Casebolt | Jul 31, 2023 | Life Sciences, Tea Leaves
The Food and Drug Administration (FDA) has approved a treatment for the prevention of RSV among infants and toddlers, making it the first preventive drug for the common virus that surged last winter among small children. The FDA approved nirsevimab-alip, or Beyfortus,...
Recent Comments